208 related articles for article (PubMed ID: 28097890)
21. Design, Synthesis and Biological Evaluation of Novel N-Pyridyl-Hydrazone Derivatives as Potential Monoamine Oxidase (MAO) Inhibitors.
Turan-Zitouni G; Hussein W; Sağlık BN; Tabbi A; Korkut B
Molecules; 2018 Jan; 23(1):. PubMed ID: 29316677
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
[TBL] [Abstract][Full Text] [Related]
23. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.
Takao K; Saito T; Chikuda D; Sugita Y
Chem Pharm Bull (Tokyo); 2016; 64(10):1499-1504. PubMed ID: 27725503
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
Prins LH; Petzer JP; Malan SF
Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
[TBL] [Abstract][Full Text] [Related]
25. Chromenylchalcones with inhibitory effects on monoamine oxidase B.
Jo G; Ahn S; Kim BG; Park HR; Kim YH; Choo HA; Koh D; Chong Y; Ahn JH; Lim Y
Bioorg Med Chem; 2013 Dec; 21(24):7890-7. PubMed ID: 24169316
[TBL] [Abstract][Full Text] [Related]
26. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
Nel MS; Petzer A; Petzer JP; Legoabe LJ
Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
[TBL] [Abstract][Full Text] [Related]
27. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
[TBL] [Abstract][Full Text] [Related]
28. 4-Organoseleno-Isoquinolines Selectively and Reversibly Inhibit the Cerebral Monoamine Oxidase B Activity.
Sampaio TB; Da Rocha JT; Prigol M; Saraiva RA; Nogara PF; Stein AL; da Rocha JB; Zeni G; Nogueira CW
J Mol Neurosci; 2016 May; 59(1):135-45. PubMed ID: 27052821
[TBL] [Abstract][Full Text] [Related]
29. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
[TBL] [Abstract][Full Text] [Related]
30. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB
Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547
[TBL] [Abstract][Full Text] [Related]
31. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors.
Morales-Camilo N; Salas CO; Sanhueza C; Espinosa-Bustos C; Sepúlveda-Boza S; Reyes-Parada M; Gonzalez-Nilo F; Caroli-Rezende M; Fierro A
Chem Biol Drug Des; 2015 Jun; 85(6):685-95. PubMed ID: 25346162
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors.
Pettersson F; Svensson P; Waters S; Waters N; Sonesson C
J Med Chem; 2012 Apr; 55(7):3242-9. PubMed ID: 22385498
[TBL] [Abstract][Full Text] [Related]
34. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
[TBL] [Abstract][Full Text] [Related]
35. (
Jin QH; Zhang LP; Zhang SS; Zhuang DN; Zhang CY; Zheng ZJ; Guan LP
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838642
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy.
Wang D; Li Z; Liu Y; Chen M; Chen N; Zuo Z; Kong DX
Future Med Chem; 2019 Apr; 11(8):801-816. PubMed ID: 31140884
[No Abstract] [Full Text] [Related]
37. The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells.
Zarmouh NO; Messeha SS; Mateeva N; Gangapuram M; Flowers K; Eyunni SVK; Zhang W; Redda KK; Soliman KFA
Molecules; 2020 May; 25(9):. PubMed ID: 32403270
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
Choi JW; Jang BK; Cho NC; Park JH; Yeon SK; Ju EJ; Lee YS; Han G; Pae AN; Kim DJ; Park KD
Bioorg Med Chem; 2015 Oct; 23(19):6486-96. PubMed ID: 26337020
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
40. Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies.
Juárez-Jiménez J; Mendes E; Galdeano C; Martins C; Silva DB; Marco-Contelles J; do Carmo Carreiras M; Luque FJ; Ramsay RR
Biochim Biophys Acta; 2014 Feb; 1844(2):389-97. PubMed ID: 24247011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
